ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000019908
Date of registration:	01/01/2016
Prospective Registration:	Yes
Primary sponsor:	Saitama Medical University International Medical Center
Public title:	Preliminary study of [11C]methionine PET/CT in the diagnosis of IgG4 related disease
Scientific title:	Preliminary study of [11C]methionine PET/CT in the diagnosis of IgG4 related disease - Preliminary study of [11C]methionine PET/CT in the diagnosis of IgG4 related disease
Date of first enrolment:	2016/01/01
Target sample size:	30
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022993
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Tomohiko Yamane
Address:	Yamane 1397-1, Hidaka Japan
Telephone:	042-984-4111
Email:	yamane@mail.ne.jp
Affiliation:	Saitama Medical University International Medical Center Nuclear Medicine

Name:	Tomohiko Yamane
Address:	Yamane 1397-1, Hidaka Japan
Telephone:	042-984-4111
Email:	yamane@mail.ne.jp
Affiliation:	Saitama Medical University International Medical Center Nuclear Medicine

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: 1) Pregnancy or possibility of pregnancy 2) Image acquisition by PET/CT is impossible due to the pain or poor performance status 3) Considered inadequate to attend this study by the researcher

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

IgG4 related disease

Intervention(s)

[11C]methionine PET/CT, [18F]FDG PET/CT

Primary Outcome(s)

1) Validation of [11C] methionine PET/CT images from the viewpoint of nuclear medicine physicians 2) Differences between [11C] methionine and [18F] FDG 3) Differences in the uptake between before and after treatment 4) Relevance to the PET uptake with clinical findings in the cases of treatment failure

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Self funding

Secondary Sponsor(s)

Saitama Medical University Hospital

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.